Healthy Volunteers Clinical Trial
— ASTIOfficial title:
Sustainable Working Life With Reduced Stress Levels - The Effects of Physical Training on Physiological and Psychological Stress-reactions and Cognitive Function.
Verified date | October 2018 |
Source | Vastra Gotaland Region |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
One of the biggest challenges of today is the high stress levels among employees in companies
and organizations. Physical exercise may be an effective preventive measure for
stress-related problems. This relatively simple and inexpensive action is believed to be
important for increasing and maintaining work ability and reduce the cost of stress-related
ill health in the workplace.
The aim is to investigate how regular physical exercise affects the individual's ability to
mentally and physiologically cope with stress. Acute stress physiological responses are
measured before and after a 6 -month intervention, where 100 untrained individuals are
randomized to either regular physical exercise or a control group.
The hypothesis is that exercise leads to lesser activation of the individual's stress
physiological systems and to an efficient physiological protection system. Mental ability to
handle stress is also studied as well as possible effects on the brain's cognitive functions.
From a work perspective, cognitive impairment due to high exposure to stress is a major
problem leading to substantial costs in businesses and organizations as a result of reduced
performance and production.
We believe that physical activity can alter and mitigate individual stress reactions. This
study brings new knowledge that can contribute to increased motivation to prioritize physical
activity in everyday life. The study could also provide evidence for businesses and
organizations of the benefits of engaging in interventions and fitness initiatives to
facilitate/enable increased physical activity in daily life for its employees. With an aging
population, we are expected to work longer, which poses a challenge as the ability to manage
stress and maintain cognitive abilities decline with age. For older employees, regular
physical activity could be an important factor directly affecting the prospects for a
sustainable working life.
Status | Completed |
Enrollment | 119 |
Est. completion date | April 3, 2017 |
Est. primary completion date | October 25, 2016 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 20 Years to 50 Years |
Eligibility |
Inclusion Criteria: - Self-reported good health - Sedentary - Work or study at least 50% Exclusion Criteria: - Diabetes - Cardiovascular disease - Blood pressure > 140/90 - Psychiatric disease - Anemia - Medication with substances that could affect any of the outcome measures |
Country | Name | City | State |
---|---|---|---|
Sweden | The Institute of Stress Medicine | Gothenburg | VGR |
Lead Sponsor | Collaborator |
---|---|
Vastra Gotaland Region |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Autonomic responses to acute psychosocial stress | Heart rate and blood pressure during and after the Trier Social Stress Test (TSST). | 6 months after start of intervention | |
Other | Neuroendocrine and autonomic responses to exercise test | 6 months after start of intervention | ||
Primary | Cortisol responses to acute psychosocial stress. | Serum cortisol (nmol/l) profile after exposure to the Trier Social Stress Test (TSST). | 6 months after start of intervention | |
Secondary | Cognitive function | Performance of the CNS Vital Signs (CNSVS) cognitive test battery. | 6 months after start of intervention | |
Secondary | Self-reported stress sensitivity and symptoms | Assessed with the Perceived Stress Scale (PSS), Coping Inventory for Stressful Situations (CISS), Shirom Melamed Burnout questionnaire (SMBQ), Hospital Anxiety and Depression scale (HAD) and Patient Health Questionnaire (PHQ-15). | 6 and 12 months after start of intervention | |
Secondary | Adrenocorticotropic hormone (ACTH) response to psychosocial stress | ACTH in plasma (pmol/L) after exposure to the TSST | 6 months after start of intervention | |
Secondary | Dehydroepiandrostreone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) response to psychosocial stress | DHEA(S) in serum (µmol/L) after exposure to the TSST | 6 months after start of the intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00995891 -
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
|
||
Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 |